Cite
Development and Validation of a Model including Arterial Enhancement Fraction to Predict the Progression in HCC Patients Undergoing Chemoembolization
MLA
Bin Chai, et al. Development and Validation of a Model Including Arterial Enhancement Fraction to Predict the Progression in HCC Patients Undergoing Chemoembolization. Apr. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........d4092ca78f785d95b19b7b8fe5b84303&authtype=sso&custid=ns315887.
APA
Bin Chai, Dongqiao Xiang, Wei Wang, Yanqiao Ren, Fuquan Wang, Jihua Wang, Yi Li, Guofeng Zhou, & Chuansheng Zheng. (2023). Development and Validation of a Model including Arterial Enhancement Fraction to Predict the Progression in HCC Patients Undergoing Chemoembolization.
Chicago
Bin Chai, Dongqiao Xiang, Wei Wang, Yanqiao Ren, Fuquan Wang, Jihua Wang, Yi Li, Guofeng Zhou, and Chuansheng Zheng. 2023. “Development and Validation of a Model Including Arterial Enhancement Fraction to Predict the Progression in HCC Patients Undergoing Chemoembolization,” April. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........d4092ca78f785d95b19b7b8fe5b84303&authtype=sso&custid=ns315887.